These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28071010)

  • 21. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
    Herrema H; IJzerman RG; Nieuwdorp M
    Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of gut microbiota in the pathogenesis of obesity and diabetes].
    Stachowicz N; Kiersztan A
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():288-303. PubMed ID: 23619228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the involvement of gut microbiota in type 2 diabetes mellitus.
    Arora A; Behl T; Sehgal A; Singh S; Sharma N; Bhatia S; Sobarzo-Sanchez E; Bungau S
    Life Sci; 2021 May; 273():119311. PubMed ID: 33662428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
    Li DY; Yang M; Edwards S; Ye SQ
    JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES.
    Passos MDCF; Moraes-Filho JP
    Arq Gastroenterol; 2017; 54(3):255-262. PubMed ID: 28723981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.
    Bekkering P; Jafri I; van Overveld FJ; Rijkers GT
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1031-41. PubMed ID: 24138599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting gut flora to treat and prevent disease.
    Schneiderhan J; Master-Hunter T; Locke A
    J Fam Pract; 2016 Jan; 65(1):34-8. PubMed ID: 26845162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gut microbiota, responsible for our body weight?].
    Pataky Z; Bobbioni-Harsch E; Hadengue A; Carpentier A; Golay A
    Rev Med Suisse; 2009 Mar; 5(196):662-4, 666. PubMed ID: 19462608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota and obesity.
    Scarpellini E; Campanale M; Leone D; Purchiaroni F; Vitale G; Lauritano EC; Gasbarrini A
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S53-6. PubMed ID: 20865475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders.
    Wang B; Wang L; Wang H; Dai H; Lu X; Lee YK; Gu Z; Zhao J; Zhang H; Chen W; Wang G
    J Nutr; 2021 Jul; 151(7):1703-1716. PubMed ID: 33982127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The microbiota of intestine. The role in development of various pathologies].
    Kuznetsova EE; Gorokhova VG; Bogorodskaya SL
    Klin Lab Diagn; 2016 Oct; 61(10):723-6. PubMed ID: 30615347
    [No Abstract]   [Full Text] [Related]  

  • 38. [Probiotics intake as gut-microbiota modulating therapy in an interdisciplinary aspect].
    Szydłowska I; Marciniak A; Malanowska E; Nawrocka-Rutkowska J; Brodowska A
    Pol Merkur Lekarski; 2020 Aug; 49(286):279-281. PubMed ID: 32827426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic syndrome and intestinal microflora: what overall?].
    Plotnikova EIu; Krasnov OA
    Eksp Klin Gastroenterol; 2014; (12):64-73. PubMed ID: 26058115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.